Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06413095
Status:
COMPLETED
Last Update Posted:
2024-05-14
First Post:
2024-04-01
Brief Title:
PBI-MST-01 NCT04541108 Substudy MSD-03 Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Sponsor:
Presage Biosciences
Organization:
Presage Biosciences
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-22
Completion Date Type:
ACTUAL
First Submit Date:
2024-04-01
First Submit QC Date:
May 8 2024
Study First Post Date:
2024-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-08
Last Update Post Date:
2024-05-14
Last Update Post Date Type:
ACTUAL